HILLEMAN JERYL L Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$5,250.00
Insider Sells Quantity
6
Insider Sells Sum
$737,293.18

Insider Activity of HILLEMAN JERYL L

According to the SEC Form 4 filings, HILLEMAN JERYL L, being in a position of

  1. director at Novocure Ltd,
    оver the last 12 months, has bought 0 shares, and sold 2945 shares for $46,445,
    over all time since 2020-12-18, has bought 0 shares, and sold 6851 share for $508,023.

Biography of HILLEMAN JERYL L

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $46,4451100

Comparison of Insiders on Amount of Buys and Sells

2026-06-02SaleNovoCure Limited
NVCR
director
2,945
0.0025%
$15.77$46,445+2.09%
2025-06-03SaleNovoCure Limited
NVCR
director
999
0.0009%
$17.26$17,247-24.65%
2023-06-20SaleSI-BONE, Inc.
SIBN
director
2,081
0.0058%
$28.00$58,268-33.42%
2023-06-15SaleSI-BONE, Inc.
SIBN
director
2,081
0.006%
$28.74$59,808-32.06%
2022-06-13SaleSI-BONE, Inc.
SIBN
1,924
0.0057%
$13.81$26,562+25.18%
2022-06-10SaleNovoCure Limited
NVCR
407
0.0004%
$69.61$28,331+8.07%
2021-06-25SaleSI-BONE, Inc.
SIBN
director
4,400
0.0133%
$33.71$148,324-36.67%
2020-12-18SaleNovoCure Limited
NVCR
director
2,500
0.0025%
$166.40$416,000-5.94%
2019-06-26PurchaseMinerva Neurosciences, Inc.
NERV
director
1,000
0.0025%
$5.25$5,250+25.05%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.